NCT00681967View on ClinicalTrials.gov

Postoperative Radiotherapy Plus Iressa or Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Head and Neck Cancer
Interventions
DRUG

Gefitinib

250 mg; oral

DRUG

Gefitinib

250mg; oral

Trial Locations (2)

Unknown

Research Site, Basel

Research Site, Bern

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT00681967 - Postoperative Radiotherapy Plus Iressa or Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck Cancer | Biotech Hunter | Biotech Hunter